Hepoer, a pharmaceutical company in Zhongshan's National Health Technology Park, launched the "Bo Lin Lan" generic isosulfan blue product for injection on December 6, filling a gap in the field of domestic solid tumor surgery.

Hepoer settled in the National Health Technology Park in Torch Development Zone in 2013. It has an R&D center in Shanghai's Zhangjiang Science City, and has established a strategic partnership with Sun Yat-sen University. Supported by the Zhongshan government in terms of customized workshop construction, policies, sci-tech services, CDMO platforms, the company has obtained more than 20 invention patents at home and abroad.

"We aim to put 5 or 6 innovative drug products into the clinical stage every year, hoping to make contributions to the high-quality development of Zhongshan's industries," said Hepoer chairman Shi Min.